EUVIMEDEUVIMED entdecken
Crossref

Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats

Ulya Keskin, Eslem Altın, Melkan Kağan Kara, Burak Tekin, Kerime Nur Çakırçoban, Fikriye Yasemin Özatik, Neziha Senem Arı, Ayşe Koçak Sezgin, Emre Güngor

Behavioural Brain Research · 2026-10 · 514 · 116343

DOI: 10.1016/j.bbr.2026.116343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2026-10. Verfasst von Ulya Keskin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kütahya Health Sciences University, School of Medicine, Department of Medical Pharmacology, Türkiye. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Hypoglycemic Agents, Memory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is associated with cognitive impairment and neurodegenerative changes, partly through hyperglycaemia-driven neuroinflammation and disrupted neuronal signalling. Retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, has shown strong metabolic efficacy, but its effects on diabetes-associated cognitive dysfunction remain unclear. The present study investigated whether Retatrutide attenuates learning- and memory-related impairments in a streptozotocin-induced, insulin-deficient diabetic rat model. Male Sprague-Dawley rats were allocated to four groups: control (C), streptozotocin-induced diabetic (STZ), streptozotocin-induced diabetic treated with Retatrutide (STZR), and Retatrutide alone (R). Diabetes was induced with streptozotocin, and spatial learning and memory were assessed using the Morris Water Maze and Passive Avoidance tests. Metabolic parameters were monitored, while hippocampal cytokine levels (IL-1β, TNF-α), BDNF, CREB, and AKT mRNA expression, Tau protein levels, and cortical and hippocampal histopathology were evaluated using biochemical, molecular, and histological methods. Streptozotocin-induced diabetes produced persistent hyperglycaemia, marked body weight loss, and impaired behavioural performance, particularly prolonged escape latencies in the Morris Water Maze and a selective short-term Passive Avoidance deficit. Retatrutide reduced blood glucose levels but did not prevent diabetes-associated weight loss. In behavioural testing, Retatrutide-treated diabetic rats showed preserved overall Morris Water Maze performance relative to untreated diabetic rats and a limited, task-dependent attenuation of short-term avoidance deficits rather than complete normalisation across all memory measures. These effects were accompanied by a significant reduction in hippocampal TNF-α, a non-significant trend toward lower IL-1β, and partial preservation of cortical and hippocampal cytoarchitecture. Retatrutide alone did not improve behavioural performance beyond control levels, although BDNF and CREB mRNA expression were increased in the non-diabetic Retatrutide group. These findings indicate that Retatrutide is associated with a partial attenuation of streptozotocin-induced behavioural and neuroinflammatory alterations in male rats. The observed effects are consistent with actions extending beyond glycaemic control alone, although direct central exposure of Retatrutide was not established in the present study. Further studies in insulin-resistant and type 2 diabetes-like models are needed to clarify the underlying mechanisms and translational relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalHypoglycemic AgentsMemoryAnimalsMaleRats, Sprague-DawleyRatsHippocampusMaze LearningAvoidance LearningCognitive EnhancementBrain-Derived Neurotrophic FactorGlucagon-Like Peptide-1 Receptor AgonistsFatty AcidsPeptides

Stichwörter der Autor:innen

Behavioural neuroscienceDiabetes-related cognitive impairmentLearning and memoryRetatrutideTriple incretin receptor agonists

Substanzen

Hypoglycemic AgentsBrain-Derived Neurotrophic FactorGlucagon-Like Peptide-1 Receptor AgonistsretatrutideFatty AcidsPeptides

Autor:innen und Institutionen

  • Kütahya Health Sciences University, School of Medicine, Department of Medical Pharmacology, Türkiye.
  • Kütahya Health Sciences University, School of Medicine, Türkiye.
  • Kütahya Health Sciences University, School of Medicine, Türkiye. Electronic address: melkankkara@hotmail.com.
  • Kütahya Health Sciences University, School of Medicine, Department of Histology and Embryology, Türkiye.
  • Kütahya Health Sciences University, School of Medicine, Department of Biochemistry, Türkiye.
  • Kütahya Health Sciences University, Faculty of Engineering and Natural Sciences, Computer Engineering, Türkiye.

Zitieren

APA

Keskin, U., Altın, E., Kara, M. K., Tekin, B., Çakırçoban, K. N., Özatik, F. Y., Arı, N. S., Sezgin, A. K., & Güngor, E. (2026). Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats. Behavioural Brain Research, 514, 116343. https://doi.org/10.1016/j.bbr.2026.116343

Vancouver

Keskin U, Altın E, Kara MK, Tekin B, Çakırçoban KN, Özatik FY, et al. Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats. Behavioural Brain Research. 2026;514:116343. doi:10.1016/j.bbr.2026.116343

BibTeX
@article{Keskin2026,
  author = {Keskin, Ulya and Altın, Eslem and Kara, Melkan Kağan and Tekin, Burak and Çakırçoban, Kerime Nur and Özatik, Fikriye Yasemin and Arı, Neziha Senem and Sezgin, Ayşe Koçak and Güngor, Emre},
  title = {Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats},
  journal = {Behavioural Brain Research},
  year = {2026},
  volume = {514},
  pages = {116343},
  doi = {10.1016/j.bbr.2026.116343}
}
Kostenlos starten →